NASDAQ:VCKA Vickers Vantage Corp. I (VCKA) Stock Price, News & Analysis → Do you know the 3 golden rules for dividend investing? (From DTI) (Ad) Free VCKA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$8.77▼$10.5052-Week Range N/AVolume1,404 shsAverage Volume36,105 shsMarket Capitalization$118.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Vickers Vantage Corp. I alerts: Email Address Ad Oasis GoldExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! About Vickers Vantage Corp. IAs of November 10, 2022, Vickers Vantage Corp. I was acquired by Scilex Holding Company, in a reverse merger transaction. Vickers Vantage Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Singapore.Read More Ad Oasis GoldExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! VCKA Stock News HeadlinesNovember 1, 2023 | morningstar.comRealty Income Corp OSeptember 8, 2023 | forbes.comClover Corp.July 8, 2023 | thestreet.comVickers Vantage Corp. I WarrantJune 26, 2023 | finance.yahoo.comKDKGF - Klondike Gold Corp.April 15, 2023 | entrepreneur.comSubchapter S CorporationFebruary 18, 2023 | marketwatch.com8-K: Lifevantage CorpFebruary 12, 2023 | investing.comVickers Vantage Corp I (VCKAU)January 29, 2023 | bizjournals.comKCI arises: Concessions manager aims to create 'extraordinary experience' for travelersNovember 15, 2022 | finance.yahoo.comThe Funded: Shares of Palo Alto's Scilex up 12% since it hit Wall Street in the Bay Area's 14th SPAC merger of 2022November 11, 2022 | seekingalpha.comShares of newly public biotech Scilex climb 5% following SPAC mergerAugust 24, 2022 | nasdaq.comVickers Vantage Corp. I Ordinary Shares (VCKA)August 17, 2022 | wsj.comVickers Vantage Corp. IJune 3, 2022 | seekingalpha.comSorrento's Scilex repurchases $41.4M notes ahead of going public with SPAC Vickers VantageJune 3, 2022 | finance.yahoo.comScilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured NotesSee More Headlines Receive VCKA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vickers Vantage Corp. I and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today6/11/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:VCKA CUSIPN/A CIK1820190 Webwww.vickersvantage.com Phone646-974-8301FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$780,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-16.72% Return on Assets1.34% Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio1.02 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow374.61 Book Value($0.91) per share Price / BookN/AMiscellaneous Outstanding Shares13,176,000Free Float10,541,000Market Cap$118.72 million OptionableNot Optionable Beta0.03 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Chien-Chuen Chi C.F.A. (Age 54)Exec. Chairman & CEO Mr. Chris Ho (Age 33)CFO & Director Key CompetitorsVoyager TherapeuticsNASDAQ:VYGRTScan TherapeuticsNASDAQ:TCRXOcugenNASDAQ:OCGNAlectorNASDAQ:ALECEditas MedicineNASDAQ:EDITView All Competitors This page (NASDAQ:VCKA) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by Au...The Freeport Society | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vickers Vantage Corp. I Please log in to your account or sign up in order to add this asset to your watchlist. Share Vickers Vantage Corp. I With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.